Skip to content
healthcare.dev

YIMMUGO

NDC 83372-605, immune globulin intravenous, human - dira, solution, from Biotest AG.

Product NDC
83372-605
Status
Listed
Labeler
Biotest AG
Dosage form
SOLUTION
Route
INTRAVENOUS
Product type
PLASMA DERIVATIVE
Marketing category
BLA
Application
BLA125810
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/83372-605 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • HUMAN IMMUNOGLOBULIN G10 g/100mL

Pharmacologic classes

Antigen Neutralization [MoA]; Human Immunoglobulin G [EPC]; Immunoglobulins [CS]; Passively Acquired Immunity [PE]

Package NDCNDC-11Package
83372-605-01833720605011 VIAL, GLASS in 1 CARTON (83372-605-01) / 50 mL in 1 VIAL, GLASS (83372-605-02)
83372-605-11833720605111 VIAL, GLASS in 1 CARTON (83372-605-11) / 100 mL in 1 VIAL, GLASS (83372-605-12)
83372-605-21833720605211 VIAL, GLASS in 1 CARTON (83372-605-21) / 200 mL in 1 VIAL, GLASS (83372-605-22)

Linked data

RxNorm, label and prices

Use it

Look up 83372-605 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/83372-605 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 83372-605. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.